ATELIER ACQ-CCC : UTILISATION JUDICIEUSE DES EXAMENS DIAGNOSTIQUES EN CARDIOLOGIE: LE BON EXAMEN POUR LE BON PATIENT AU BON MOMENT (CCC-185)

Saturday, October 28, 2023

11:00 – 11:45 EST

Location: Palais, 513DEF

Target Audience: General: All cardiovascular (clinical and research) health professionals, Clinical cardiologists, Trainee (clinical)

Chair(s)

Benoît M-Labbé, MD, MSc, FRCPC, FACC

Cardiologue échocardiographiste
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)
Université Laval

Co-Chair(s)

IN

Isabelle Nault Nault, MD, FRCPC (she/her/hers)

Cardiac Electrophysiologist
Institut Universitaire de Cardiologie et de Pneumologie de Québec
Université Laval

Presenter(s)

BD

Benoit Daneault, MD

Professeur agrégé Université de Sherbrooke, Cardiologue d'intervention CHUS
Centre hospitalier universitaire de Sherbrooke
Université de Sherbrooke
Emilie Laflamme (she/her/hers)

Cardiologue
Institut Universitaire de Cardiologie et de Pneumologie de Québec
Vy-Van Le, MD, FRCPC

Professeur adjoint clinique, Cardiologue échographiste
Centre Hospitalier de l'Université de Montréal
Université de Montréal

Disclosure(s):

Benoît M-Labbé, MD, MSc, FRCPC, FACC: No financial relationships to disclose

Isabelle Nault Nault, MD, FRCPC: Bayer: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing); Servier: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Benoit Daneault, MD: 4C Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Abbott: Speaker/Honoraria (Ongoing); Alleviant: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Amgen: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); AstraZeneca: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); BI: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Microport: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novartis: Speaker/Honoraria (Ongoing); Novo-Nordisk: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Shockwave: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Soundbite: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Emilie Laflamme: No financial relationships to disclose

Vy-Van Le, MD, FRCPC: No financial relationships to disclose

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

discuss relevant and appropriate use of exercice stress test, for the diagnosis and follow up of coronary heart disease;
discuss the relevant and appropriate use of transthoracic echocardiography study for the follow up of valvular heart disease including non severe, and in the investigation workup for dyspnea; and
discuss the relevant and appropriate use of nuclear medicine coronary perfusion study, in the investigation for chest pain and in patients with suspected or know coronary heart disease.

Workshop Description: This workshop is intended to be presented in French, as part of the partnership between the CCC and the ACQ.

This workshop will fulfill the learning needs of those seeking a comprehensive overview of the appropriate use of diagnostic modalities in cardiology. Clinical scenarios like those addressed in this workshop represent frequent clinical situations in which all clinicians involved in the clinical management of patients are exposed. This workshop will provide participants with a comprehensive and practical approach to the use of common diagnostic modalities in cardiology. It will then discuss in more detail the strengths and limits of modalities in common specific clinical questions.

The ACQ CME committee planned this workshop. Members of this committee include community and academic cardiologists and cardiology residents from diverse practices and experience across Quebec. The ACQ CME has developed an objective and balanced representation of the topic of " Atelier ACQ-CCC: Utilisation judicieuse des examens diagnostiques en cardiologie: choisir le bon examen pour le bon patient, au bon moment.” that is completely free of third-party influence and/or support. Selected speakers from across Quebec are representative of diversity in gender, generation and practice.